International Clinical Trial: A randomized, double-blind, placebo-controlled, multicenter clinical study on the treatment of stable chronic obstructive pulmonary disease (COPD) with Pseudomonas aeruginosa injection (PA-MSHA fimbrial strain inactivated preparation)

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115870) titled 'A randomized, double-blind, placebo-controlled, multicenter clinical study on the treatment of stable chronic obstructive pulmonary disease (COPD) with Pseudomonas aeruginosa injection (PA-MSHA fimbrial strain inactivated preparation)' on Dec. 31, 2025.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Peking University Third Hospital

Condition: Stable chronic obstructive pulmonary disease (COPD)

Intervention: Placebo group:Routine basic treatment for chronic obstructive pulmonary disease (COPD)

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-01 ...